Glaxo Sells Stake in South Africa’s Aspen for $619 MillionBy
Aspen shares have risen 6-fold over the seven-year investment
Glaxo sold two further tranches of Aspen shares in 2013, 2015
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.
You might like: